Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Ellis currently holds 25,075 shares of Vaccitech plc (VACC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Ellis has been a net seller of VACC stock. They have purchased $1.3K and sold $309.2K worth of shares.
Christopher Ellis's most recent insider trade was on Aug 25, 2022, when they sold 14,176 shares at $5.69 per share.
Christopher Ellis serves as Executive at Vaccitech plc (VACC). They have executed 16 insider transactions totaling $310.5K over their tenure at the company.
Christopher Ellis holds the position of Executive at Vaccitech plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Christopher Ellis has shown a selling trading pattern, with $1.3K in total purchases and $309.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher Ellis was on Aug 25, 2022, when they sold $176.8K worth of VACC shares. This transaction involved 25,000 shares at $7.07 per share.
Christopher Ellis currently owns 25,075 shares of Vaccitech plc (VACC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Ellis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Ellis has 16 Form 4 filings on record as an insider at Vaccitech plc.
Set alerts for Christopher Ellis and 40,000+ other insiders.